awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42126450-8F0B6F22-2C0A-44A0-881F-2377254DBF09
Q42126450-8F0B6F22-2C0A-44A0-881F-2377254DBF09
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42126450-8F0B6F22-2C0A-44A0-881F-2377254DBF09
Tumor Reduction in Primary and Metastatic Pancreatic Cancer Lesions With nab-Paclitaxel and Gemcitabine: An Exploratory Analysis From a Phase 3 Study.
P2860
Q42126450-8F0B6F22-2C0A-44A0-881F-2377254DBF09
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42126450-8F0B6F22-2C0A-44A0-881F-2377254DBF09
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9ac95ae6efe4c0b48aebc2cc34e924f19cea1c9c
P2860
Prognostic factors of survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer.